RIP: novel human protein involved in tumor necrosis factor signal transduction
US6211337A · kind A · utility
2Cited by
1References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 11, 1998 |
| Grant date | Apr 3, 2001 |
| Priority date | — |
| Expiry date | Aug 11, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a human Receptor Interacting Protein (hRIP), nucleic acids which encode hRIP and methods of using the subject compositions; in particular, methods such as hRIP-based in vitro binding assays and phosphorylation assays for screening chemical libraries for lead compounds for pharmacological agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.